$ABBV News

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

AbbVie Inc. (ABBV) Announces EC Authorization of Expanded Label for VENCLYXTO®

The S&P 500 Is Expensive, but These 3 Dividend Stocks Still Look Like Bargains

Is AbbVie Inc. (ABBV) Expanding Its Oncology Pipeline With New BPDCN Treatment Approval?

AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

AbbVie (ABBV) Up 3.5% Since Last Earnings Report: Can It Continue?

AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia

AbbVie Says EC Authorizes Expanded Label For VENCLYXTO To Include Use In Combination With Acalabrutinib And Use In Combination With Ibrutinib For The Treatment Of Adult Patients With Previously Untreated Chronic Lymphocytic Leukemia

AbbVie Wins FDA Nod for Decnupaz for Rare Blood Cancer Indication

U.S. FDA Approves DECNUPAZTM (pivekimab sunirine-pvzy) for Treatment of Adult Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare and Aggressive Blood Cancer With Limited Treatment Options

ABBV Stock Gains On Winning FDA Approval For Rare Blood Cancer Drug

How Did AbbVie's Oncology Portfolio Perform in Q1 Despite Headwinds?

FDA Approves Pivekimab Sunirine-pvzy For Blastic Plasmacytoid Dendritic Cell Neoplasm, An Ultra-Rare Hematologic Malignancy

Piper Sandler Raises Price Target on AbbVie (ABBV) Amid Strong IBD Pipeline Progress

Final Trades: AbbVie, Deckers and Goldman Sachs

What's the Better Dividend Stock Today: AbbVie or Pfizer?

AbbVie Expands European Reach As Investors Weigh Dividend Support

AbbVie (ABBV): 10 Best Low Risk Stocks to Buy in 2026

Final Trades: AbbVie, Millrose Properties, Archer-Daniels-Midland, GE Vernova and Estee Lauder

AbbVie Announces Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) for the Treatment of Acute Hepatitis C Infection